Vaginal DNA Assay Shows Promise

A two-marker methylated DNA assay identified endometrial cancer with 96% sensitivity in self-collected vaginal fluid — but prospective validation is needed before it can reduce biopsies in routine care.

By
Kerri Miller
May 8, 2026
14 min

Conexiant

Top Institutions in Obgyn

Brief introduction explaining scope and methodology.

#1

Mayo Clinic

Rochester, MN
Key Differentiators
- Obstetrics and Gynecology
#2

Dana-Farber Cancer Institute

Boston, MA
Key Differentiators
- Oncology
- Gynecologic Oncology
#3

Stanford University

Stanford, CA
Key Differentiators
- Obstetrics and Gynecology
- Oncology
#4

The University of Texas MD Anderson Cancer Center

Houston, TX
Key Differentiators
- Oncology
- Gynecologic Oncology
#5

University of California, San Francisco (UCSF)

San Francisco, CA
Key Differentiators
- Obstetrics and Gynecology
- Oncology